Pulmonary Hypertension | Norton Healthcare

Indication: Pulmonary Hypertension

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease

Sub-indication: Pulmonary Hypertension

Drug Study

Principal Investigator: John McConnell, M.D.
Norton Pulmonary Specialists

Sponsor: UNITED THERAPEUTICS CORPORATION

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.